| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 11.57 | 12.9% | 83.7% |
| Total Income | 11.57 | 12.9% | 83.7% |
| Expenditure | 55.90 | 0.3% | 27.6% |
| PBT | -44.52 | 0.8% | 314.1% |
| Net Profit | -35.53 | 111.9% | 230.5% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.31 | 112.1% | 244.4% |
Coherus Oncology Reports Q3 2025 Financial Results
04 May 2026 · 4 May, 7:49 am
Summary
Coherus Oncology, Inc. issued a press release on November 6, 2025, regarding its financial results for the fiscal quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 to the Form 8-K.
Informational and educational content only. Not investment advice.